Skip to main navigation Skip to search Skip to main content

SBIR Phase I: Development of AI Software to Capture and Identify Circulating Rare Cells in Lung Patients

Project: Research

Abstract & Details

Description

Award ID: 2015008

This broader impacts/commercial potential of this SBIR Phase I NSF project is to develop Artificial Intelligence (AI) software to identify circulating lung cancer related cells efficiently and accurately. It is estimated that there will be over 200,000 new cases of lung cancer in the US in 2020, driving the cost above $166 billion. The current standard of care requires close monitoring of these patients, with chest Computed Tomography (CT) scans taken every 6 weeks. Patients also undergo pelvis CT scans concurrently if their cancer is determined to be at later stages. The proposed technology will provide the clinician additional data for early detection of lung cancer with a simple blood draw in a clinical laboratory setting for immediate feedback to the patient and clinician, thus avoiding more invasive procedures and radiation exposures. The proposed project will advance liquid biopsy techniques in R&D clinical settings. This projects novel imaging systems ability to identify the fluorescent tumor-derived cells will provide a more sensitive and reliable methodology to detect early-stage disease and differentiate indolent from aggressive lung cancer, with further potential to be integrated into lung cancer screening programs. Utilizing advanced Artificial Intelligence (AI) algorithms and world-class optical immunofluorescent detection methods, this projects fluorescent microscope will be an AI-driven image processing system. This project provides an unprecedented solution for detecting low levels of rare cells in a clinical setting through the combination of high resolution multichannel optical imaging, proprietary fluorescent taggants and assays, and state-of-the-art AI segmentation and classification techniques. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

NSF Program Director: Henry Ahn
StatusClosed
Effective start/end date06/01/2011/30/21

Funding

  • SBIR Phase I: $224,426.00

Active Fiscal Year

  • FY2022

Start Fiscal Year

  • FY2020

TIP Programs

  • SBIR Phase I

Small Business

  • Yes

Key Technology Areas

  • Artificial Intelligence
  • (confidence score: 98%)
  • Biotechnology
  • (confidence score: 100%)

Technology Foci

  • Genomics and bioinformatics
  • (confidence score: 90%)
  • Artificial Intelligence (Broad)
  • (confidence score: 100%)

Congressional District at Award

  • District n. 05 of Virginia

Current Congressional District

  • District n. 05 of Virginia

United States

  • Virginia

Core Based Statistical Area (CBSA)

  • Charlottesville, VA

County

  • County: Albemarle, VA

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine